| Entry |
|
|---|
| Name |
Ganciclovir sodium (USAN);
Cytovene IV (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C9H12N5O4. Na
|
|---|
| Exact mass |
277.0787
|
|---|
| Mol weight |
277.2124
|
|---|
| Structure |
   |
|---|
| Simcomp |
 |
|---|
| Class |
Antiviral
DG02840 Herpesvirus DNA polymerase inhibitor
DG01937 Anti-cytomegalovirus agent
|
|---|
| Remark |
| Product (DG00646): | D00333<JP/US> D04301<US> |
|
|---|
| Efficacy |
Antiviral, DNA polymerase inhibitor |
|---|
| Disease |
|
|---|
| Target |
Herpesvirus DNA polymerase [KO: K18964] |
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB06 Ganciclovir
D04301 Ganciclovir sodium (USAN) <US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD09 Ganciclovir
D04301 Ganciclovir sodium (USAN) <US>
USP drug classification [BR:br08302]
Antivirals
Anti-cytomegalovirus (CMV) Agents
Ganciclovir
D04301 Ganciclovir sodium (USAN)
Ophthalmic Agents
Ophthalmic Anti-Infectives
Antiviral, Ophthalmic
Ganciclovir
D04301 Ganciclovir sodium (USAN)
Antiinfectives [br08350.html]
Antivirals
D04301
 |
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 19
1 N4y N 17.7005 -17.0904
2 C8y C 18.9563 -16.6020
3 C8y C 18.9563 -15.2067
4 N5x N 17.6307 -14.8578
5 C8x C 16.8633 -15.9741
6 N5x N 20.3516 -17.2997
7 C8y C 21.3981 -16.5322
8 N5x N 21.3981 -15.1369
9 C8y C 20.1423 -14.5090
10 O1a O 20.1423 -13.1137 #-
11 N1a N 22.6539 -17.2299
12 C1b C 17.7005 -18.5554
13 O2a O 16.5145 -19.2531
14 C1c C 15.2587 -18.5554
15 C1b C 14.1424 -19.2531
16 C1b C 15.2587 -17.0904
17 O1a O 14.0726 -16.3927
18 O1a O 12.8866 -18.5554
19 Z Na 21.9480 -12.8288 #+
BOND 19
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 1 5 1
6 2 6 1
7 6 7 2
8 7 8 1
9 8 9 2
10 3 9 1
11 9 10 1
12 7 11 1
13 1 12 1
14 12 13 1
15 13 14 1
16 14 15 1
17 14 16 1
18 16 17 1
19 15 18 1
|
|---|
